Barbara Eifrig

506 total citations
23 papers, 416 citations indexed

About

Barbara Eifrig is a scholar working on Hematology, Genetics and Internal Medicine. According to data from OpenAlex, Barbara Eifrig has authored 23 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 5 papers in Genetics and 5 papers in Internal Medicine. Recurrent topics in Barbara Eifrig's work include Blood Coagulation and Thrombosis Mechanisms (10 papers), Platelet Disorders and Treatments (9 papers) and Hemophilia Treatment and Research (7 papers). Barbara Eifrig is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (10 papers), Platelet Disorders and Treatments (9 papers) and Hemophilia Treatment and Research (7 papers). Barbara Eifrig collaborates with scholars based in Germany, United States and Austria. Barbara Eifrig's co-authors include Florian Länger, Carsten Bokemeyer, Brigitte Spath, Ali Amirkhosravi, Katharina Holstein, Felix K.‐H. Chun, Martin Friedrich, John Francis, Jan Wierecky and K. Gutensohn and has published in prestigious journals such as Blood, Thrombosis and Haemostasis and Journal of Thrombosis and Haemostasis.

In The Last Decade

Barbara Eifrig

23 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Eifrig Germany 13 285 122 103 78 51 23 416
R. Consonni Italy 12 393 1.4× 235 1.9× 214 2.1× 94 1.2× 53 1.0× 17 561
M.C. Trzeciak France 12 318 1.1× 72 0.6× 63 0.6× 39 0.5× 21 0.4× 20 424
Thomas Sailer Austria 10 308 1.1× 113 0.9× 39 0.4× 31 0.4× 20 0.4× 14 450
Nabil Saba United States 3 260 0.9× 50 0.4× 213 2.1× 168 2.2× 26 0.5× 4 476
Alexander T. Hardy United Kingdom 7 199 0.7× 37 0.3× 28 0.3× 50 0.6× 37 0.7× 8 337
Abraham Avigdor Israel 10 111 0.4× 26 0.2× 108 1.0× 76 1.0× 133 2.6× 14 426
Janet I. Malowany Canada 9 163 0.6× 99 0.8× 40 0.4× 35 0.4× 58 1.1× 10 345
Marco Santoro Italy 13 150 0.5× 48 0.4× 89 0.9× 161 2.1× 50 1.0× 48 386
Hassan Sibai Canada 11 226 0.8× 33 0.3× 87 0.8× 118 1.5× 59 1.2× 69 369
Sudha Parasuraman United States 8 96 0.3× 83 0.7× 38 0.4× 69 0.9× 102 2.0× 15 304

Countries citing papers authored by Barbara Eifrig

Since Specialization
Citations

This map shows the geographic impact of Barbara Eifrig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Eifrig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Eifrig more than expected).

Fields of papers citing papers by Barbara Eifrig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Eifrig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Eifrig. The network helps show where Barbara Eifrig may publish in the future.

Co-authorship network of co-authors of Barbara Eifrig

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Eifrig. A scholar is included among the top collaborators of Barbara Eifrig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Eifrig. Barbara Eifrig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holstein, Katharina, Barbara Eifrig, & Florian Länger. (2014). Relationship between haemophilia and social status. Thrombosis Research. 134. S53–S56. 12 indexed citations
2.
Zimmermann, R., et al.. (2012). [Haemophilia treatment centres in Germany].. PubMed. 32 Suppl 1. S12–9. 1 indexed citations
3.
Mackensen, Sylvia von, et al.. (2012). The impact of a specific aqua‐training for adult haemophilic patients – results of the WATERCISE study (WAT‐QoL). Haemophilia. 18(5). 714–721. 22 indexed citations
4.
Wermes, C., Barbara Eifrig, Katharina Holstein, et al.. (2011). Inhibitor-Immunology-Study. Hämostaseologie. 31(S 01). S57–S60. 1 indexed citations
5.
6.
Länger, Florian, Brigitte Spath, Katharina Holstein, et al.. (2008). Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation. Annals of Hematology. 87(6). 451–457. 79 indexed citations
7.
Wermes, C., Barbara Eifrig, Katharina Holstein, et al.. (2008). Inhibitor-Immunology-Study. Hämostaseologie. 28(S 01). S26–S28. 5 indexed citations
9.
Chun, Felix K.‐H., Ali Amirkhosravi, Martin Friedrich, et al.. (2007). Plasma tissue factor antigen in localized prostate cancer: Distribution, clinical significance and correlation with haemostatic activation markers. Thrombosis and Haemostasis. 97(3). 464–470. 28 indexed citations
10.
Länger, Florian, Ali Amirkhosravi, Susan B. Ingersoll, et al.. (2006). Experimental metastasis and primary tumor growth in mice with hemophilia A. Journal of Thrombosis and Haemostasis. 4(5). 1056–1062. 42 indexed citations
11.
Weber, Martin S., et al.. (2005). Platelet Activation Markers in Patients with Venous Thromboembolism without Predisposing Factors. Pathophysiology of Haemostasis and Thrombosis. 34(1). 1–5. 8 indexed citations
12.
Amirkhosravi, Ali, Sonja Loges, Todd Meyer, et al.. (2004). An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF. Thrombosis and Haemostasis. 92(11). 1136–1146. 18 indexed citations
13.
Willems, Marc, Martina Sterneck, Florian Länger, et al.. (2003). Recurrent deep-vein thrombosis based on homozygous factor V Leiden mutation acquired after liver transplantation. Liver Transplantation. 9(8). 870–873. 14 indexed citations
14.
Weber, Michael, Nicolaus Kröger, Florian Länger, et al.. (2003). Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 31(9). 817–822. 18 indexed citations
15.
Länger, Florian, Barbara Eifrig, Gerald R. Marx, et al.. (2002). Exacerbation of antiphospholipid antibody syndrome after treatment of localized cancer: a report of two cases. Annals of Hematology. 81(12). 727–731. 19 indexed citations
16.
Gutensohn, K., et al.. (2002). Platelet function testing in apheresis products: flow cytometric, resonance thrombographic (RTG) and rotational thrombelastographic (roTEG) analyses. Transfusion and Apheresis Science. 26(3). 147–155. 21 indexed citations
17.
Weber, Martin S., et al.. (2002). Enhanced platelet aggregation with TRAP-6 and collagen in platelet aggregometry in patients with venous thromboembolism. Thrombosis Research. 107(6). 325–328. 20 indexed citations
18.
Eifrig, Barbara, et al.. (2001). Thrombophiliefaktoren als Auslöser retinaler Gefäßverschlüsse. Der Ophthalmologe. 98(6). 529–534. 6 indexed citations
19.
Eifrig, Barbara, et al.. (2000). Die perioperative Behandlung von Patienten mit hereditärem Angioödem (HAE) am Beispiel eines Jugendlichen mit Osteosynthese einer Oberschenkelfraktur. AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 35(12). 776–781. 3 indexed citations
20.
Gutensohn, K., et al.. (1999). Biocompatibility of a new cell separator studied by flow cytometry: analyses of platelet antigens during apheresis and storage. Transfusion. 39(7). 742–747. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026